Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
about
The Promises of Quantitative Proteomics in Precision MedicineCharacterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter.Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative ProteomicsClinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.Harnessing Solute Carrier Transporters for Precision Oncology.Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children.Aprepitant and fosaprepitant drug interactions: a systematic review.Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.OCT1 pharmacogenetics in pain management: is a clinical application within reach?Transporter expression in non-cancerous and cancerous liver tissue from donors with hepatocellular carcinoma and chronic hepatitis C infection quantified by LC-MS/MS proteomics.Ontogeny-related pharmacogene changes in the pediatric liver transcriptome.Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-sulfate, A Major Circulating Vitamin D Metabolite in Humans.Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.
P2860
Q37647264-646B60A9-2AC5-4760-BDA5-127347A7B783Q37660713-87F5F4B4-F0A6-4BDB-B137-30E509AB50ACQ38829596-699EEF5F-0D50-4271-A854-06A5FC058931Q39004656-C536CA4D-0208-422D-804F-925735463A74Q39038877-40B6D26C-C1CE-48CA-A7BD-C2894ECD65A0Q39147483-CA1A5207-946C-431F-B5D1-05E5AE5D0A5BQ39204754-059E21BF-4731-4F1E-A133-0F8707C8F576Q39250108-EE51EB86-13E1-46BE-AE21-3ED3B38358C6Q39282847-0E0D7855-431C-425C-A914-51AC8B24DB4EQ39398250-254A1943-8ED9-4974-9A20-03F49272D4FDQ41640455-B0368934-A6C4-49CE-B054-45127C2EADB3Q43075700-AF596DB2-EDDF-46EA-AA5E-D5D5B5F5E656Q47402203-D9DC1C61-76D4-4903-9422-B0E597382D79Q48512362-B10A29E1-9BE1-4880-9ACD-C273D1CD77DEQ49989942-49CA5C8F-10CE-49E8-8E72-A187882429C1Q50948139-3D97A009-E811-4CBF-B41A-E84AA0E05B8F
P2860
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@en
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@nl
type
label
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@en
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@nl
prefLabel
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@en
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@nl
P2093
P2860
P356
P1476
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
@en
P2093
J D Unadkat
J S Leeder
L Salphati
P2860
P304
P356
10.1002/CPT.409
P407
P577
2016-06-15T00:00:00Z